Moses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
JD & SN Inc. is recalling 18-pellet vials of 76 mg Testosterone Pellets because the FDA determined there is a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility, which is a significant safety hazard for a sterile compounded drug.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling 18-pellet vials of 76 mg Testosterone Pellets. The recall was initiated because the U.S. Food and Drug Administration determined there is a lack of assurance of sterility for the product. The agency classification for this recall is Class II.
The affected product is a prescription-only compounded drug. The recall covers specific lots identified by the codes t12172014@7, t12092014@16, t10062014@26, t08252014@4, t05292015@3, t05212015@18, t05052014@11, t04012015@1, t01202015@15, and t01052015@30. The distribution pattern for these products is listed as nationwide.
Consumers who have this product should contact their healthcare provider or the recalling firm, JD & SN Inc., for instructions on how to return the product or obtain a replacement. The firm can be reached at (509) 764-2314.
The recalled product
- Product
- TESTOSTERONE, Pellet, 76 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Hazard
- Affected units
- 18
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- t12172014@7
- t12092014@16
- t10062014@26
- t08252014@4
- t05292015@3
- t05212015@18
- t05052014@11
- t04012015@1
- t01202015@15
- t01052015@30.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighQualgen Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- SevereQualgen Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2018-11-14
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- HighRecall of Testosterone 12.5mg Pellet due to Sterility Concerns
FDA (Drugs) · 2018-11-14
- SevereTestosterone Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereTestosterone and B12 Pellet Recalled for Sterility Assurance Issues
FDA (Drugs) · 2015-09-23